Table 2.

Natural products against hematogical malignancies in clinical trials

NATURAL PRODUCTS	CANCER TYPE	STATUS	STUDY PHASE	Clinical trials.gov number
Homoharringtonine	CML	COMPLETED	PHASE 2	NCT00375219 (a)
Tanespimycin (17-AAG)	AML	COMPLETED	PHASE 1	NCT00098423 (b)

^a https://clinicaltrials.gov/ct2/show/record/NCT00375219?term=omacetaxine&cond=LEUKEMIA&draw=1&rank=2

^b https://clinicaltrials.gov/ct2/show/NCT00098423?term=17-AAG&cond=Leukemia&draw=1&rank=6